A detailed history of Keb Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Keb Asset Management, LLC holds 3,775 shares of ABT stock, worth $427,669. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,775
Previous 3,908 3.4%
Holding current value
$427,669
Previous $406,000 5.91%
% of portfolio
0.15%
Previous 0.16%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$100.07 - $118.13 $13,309 - $15,711
-133 Reduced 3.4%
3,775 $430,000
Q2 2024

Jul 25, 2024

BUY
$100.73 - $112.44 $1,208 - $1,349
12 Added 0.31%
3,908 $406,000
Q1 2024

Apr 24, 2024

BUY
$109.52 - $120.96 $34,170 - $37,739
312 Added 8.71%
3,896 $442,000
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $36,346 - $44,491
403 Added 12.67%
3,584 $394,000
Q3 2023

Nov 01, 2023

BUY
$95.53 - $114.62 $764 - $916
8 Added 0.25%
3,181 $308,000
Q2 2023

Jul 28, 2023

BUY
$100.78 - $112.29 $806 - $898
8 Added 0.25%
3,173 $345,000
Q1 2023

May 03, 2023

BUY
$96.86 - $114.01 $774 - $912
8 Added 0.25%
3,165 $320,000
Q4 2022

Feb 06, 2023

BUY
$95.06 - $111.52 $760 - $892
8 Added 0.25%
3,157 $346,000
Q3 2022

Oct 27, 2022

BUY
$96.76 - $112.03 $40,735 - $47,164
421 Added 15.43%
3,149 $305,000
Q2 2022

Aug 09, 2022

BUY
$102.07 - $123.37 $612 - $740
6 Added 0.22%
2,728 $296,000
Q1 2022

May 09, 2022

SELL
$114.02 - $139.04 $19,497 - $23,775
-171 Reduced 5.91%
2,722 $322,000
Q4 2021

Feb 08, 2022

BUY
$115.53 - $141.46 $334,228 - $409,243
2,893 New
2,893 $407,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Keb Asset Management, LLC Portfolio

Follow Keb Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keb Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keb Asset Management, LLC with notifications on news.